Approval · Notice of Compliance 5893 · 1994
CAPOTEN: Notice of Compliance 5893
Issued February 10, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5893
- Date
- February 10, 1994
- Company
- Squibb Canada Inc., Division Of Bristol-Myers Squibb Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate source of raw material, change in manufacturing
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAPOTEN | Not yet assigned | — |